EP1549770 - Bibliographic data
METHODS TO PREDICT CHOLESTEROL ELEVATIONS DURING IMMUNOSUPPRESSANT THERAPY
| Last update | 01/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
NOVARTIS AG Lichtstrasse 35
4056 s
BASEL
Suisse
NOVARTIS PHARMA GMBH Brunner Strasse 59
1230 Wien
Autriche
|
|---|---|
| (72) Inventors |
KUDARAVALLI, Sridhar 1401 E.Hyde Park Boulevard,Apt .405
Chicago, IL 60615
États-Unis d'Amérique
POLYMEROPOULOS, Mihael, Hristos 11300 Ridge Mist Terrace
Potomac, MD 20854
États-Unis d'Amérique
TORRES, Rosarelis 5317 King Charles Way
Bethesda, MD 20814
États-Unis d'Amérique
WOLFGANG, Curt, Douglas 13331 Neerwinder Place
Germantown, MD 20874
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient MORRIS, CLIVE SYDNEY Corporate Intellectual Property Novartis AG
4002 Basel
Suisse
|
| (21) Request number | EP03779798.2 |
|---|---|
| (22) Request date | 29/09/2003 |
| (11) Publication number | EP1549770 |
|---|---|
| Publication date | 12/03/2008 |
| (54) Title of the invention | METHODS TO PREDICT CHOLESTEROL ELEVATIONS DURING IMMUNOSUPPRESSANT THERAPY |
|---|---|
| (51) International classification | C12Q 1/68 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 415123 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 6 -
Amount: 75 € -
Due date 30/09/2008
Surtax: 6 - Amount: 15 € - Due date 31/03/2009 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2008/1, of 01/03/2008 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 12/03/2008 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2008 Entrée en période de grâce du brevet d'invention - Legal date 30/09/2008 |